Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 219

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 219
---
, Director |
| Stephen Parker (3)(4)                |     |         66 |     | Non-Executive Chairman of the Board of Directors              |
| Simon Turton, Ph.D. (2)(3)(4)        |     |         57 |     | Senior Independent Non-Executive Director                     |
| Sijmen (Simon) de Vries, M.D. (2)(4) |     |         65 |     | Non-Executive Director                                        |
| Ann Merchant (2)(3)                  |     |         59 |     | Non-Executive Director                                        |

__________________________

| (1) | The term of the Board of Directors will expire immediately after the annual general meeting held in 2027 
 for Dr. de Vries, 2026 for Mr. Stamp, Dr. Parker and Ms. Merchant, and 2025 for Dr. Turton.              |

| (2) | Remuneration Committee member |

| (3) | Audit Committee member |

| (4) | Nominations Committee member |

Stephen Stamp has served
as our Chief Executive Officer since March 31, 2020, and our Chief Financial Officer and a member of our Board of Directors since September
2019. Prior to joining the Company, Mr. Stamp served as Chief Executive Officer of Ergomed plc (AIM: ERGO) from December 2017 until January
2019 and Chief Financial Officer from January 2016 to July 2018. From March 2013 until July 2015, Mr. Stamp served as the Chief Financial
Officer of Assurex Health, Inc. Mr. Stamp served as Chief Financial Officer of EZCORP Inc. (NASDAQ: EZPW) and KV Pharmaceuticals Co. from
November 2010 to October 2012 and March 2010 to June 2010. Mr. Stamp has also previously served as Chief Operating Officer of Xanodyne
Pharmaceuticals, Inc., and Group Finance Director of Regus PLC (now IWG plc) (LON: IWG) and Shire plc (subsequently acquired by Takeda
Pharmaceuticals Company Limited). Mr. Stamp is a Chartered Accountant and qualified with KPMG LLP. Mr. Stamp has a Bachelor’s degree
in economics from the University of Manchester.

Stephen Parker has
served as our Non-Executive Chairman of the Board of Directors and a director since June 2022.Dr. Parker has a